logo
Select company
Select metric
$ 79.97MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
55
Sector
84
Industry
95
History
100
$ 5.53Close
$ 4.18 - $ 7.23 52-Week Range
Ticker Information

Ticker

ABEO

Company Name

ABEONA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABEONA THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABEO - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 3.08M$ 76.89M$ 79.97M
3/31/2025$ 3M$ -39.93M$ -36.93M
12/31/2024$ 2.91M$ -59.53M$ -56.62M
9/30/2024$ 2.85M$ -67.8M$ -64.94M
6/30/2024$ 2.88M$ -50.36M$ -47.48M
3/31/2024$ 3.03M$ -75.39M$ -72.36M
12/31/2023$ 3.2M$ -53.77M$ -50.57M
9/30/2023$ 3.49M$ -38.24M$ -34.75M
6/30/2023$ 3.82M$ -35.83M$ -32.01M
3/31/2023$ 4.35M$ -27.26M$ -22.91M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ABEONA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -74.28M.
  • Over the past 5 years, ABEONA THERAPEUTICS INC's average EBITDA has been $ -48.48M.
  • The median EBITDA for ABEONA THERAPEUTICS INC during this period was $ -49.03M
  • ABEONA THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 79.97M.
  • The lowest EBITDA recorded by ABEONA THERAPEUTICS INC in the same timeframe $ -82.78M

ABEONA THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
MREO : MEREO BIOPHARMA GROUP PLC $ -49.23MCRDF : CARDIFF ONCOLOGY INC $ -50.37MCOYA : COYA THERAPEUTICS INC $ -21.03MAVTX : AVALO THERAPEUTICS INC $ -47.9MABVC : ABVC BIOPHARMA INC $ -2.42MIBIO : IBIO INC $ -17.04MMBX : MBX BIOSCIENCES INC $ -76.63MATXS : ASTRIA THERAPEUTICS INC $ -116.92MLRMR : LARIMAR THERAPEUTICS INC $ -99.7MPULM : PULMATRIX INC $ -7.93M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ABEONA THERAPEUTICS INC is calculated as follows: EBIT [ $ -81.71M ] + DepAmor [ $ 7.43M ]
(=) EBITDA [ $ -74.28M ]

ABEO - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -82.78M

Minimum

Mar 31, 2022

$ 79.97M

Maximum

Jun 30, 2025

$ -48.48M

Average

$ -49.03M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.77M with a standard deviation of $ 166.95M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.77M
median$ 8.83M
std$ 166.95M